AGP Picks
View all

Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on July 1, 2026

YRC Study: Hypermarket Model Under Attack, Quick Commerce, Discount Chains, and Online Grocery Closing In Fast
جيتور تستضيف النسخة الثانية من كرنفال سيارات SUV الصندوقية لتعزيز ثقافة السفر والقيادة على الطرق الوعرة
Best 5 Packaging Machine Manufacturers in China
Classiq and QAI Launch Quantum Cloud Offering in Korea
Regus, Cottages & Gardens and Avis Join 200 Connecticut Avenue in Norwalk
Bitcoin loses over 26,000 millionaire addresses in first half of 2026, Finbold report finds
Oil Refining Market Growth Fueled by Transportation and Petrochemical Expansion
Grand Outlaws Launches Globally in Late Summer 2026 — Open Beta Already Live on Android
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
Arobis AI Research Exposes the Silent Demand Gap Costing SaaS Companies Pipeline Before a Website Is Ever Visited
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
Creative Medical Technology Holdings Issues Mid-Year Update
Cyabra Recognized as a Market Shaper in the Inaugural June 2026 Gartner® Emerging Market Quadrant for Narrative Intelligence— Startup Vendors, as AI-Driven Manipulation Reshapes Digital Trust
Türkiye’s leading digital asset platform Paribu expands its platform into DeFi, yield, and equities
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.